IDEXX Laboratories (IDXX) Stock Forecast & Price Target

$544.32 +4.96 (+0.92%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$544.09 -0.23 (-0.04%)

As of 07/24/2026 07:34 PM Eastern

Compare

IDEXX Laboratories - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 10 Analyst Ratings

Sell
0

Hold
4

Buy
6

Based on 10 Wall Street analysts who have issued ratings for IDEXX Laboratories in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 4 have given a hold rating, and 6 have given a buy rating for IDXX.

Consensus Price Target

$751.00
37.97% Upside

According to the 10 analysts' twelve-month price targets for IDEXX Laboratories, the average price target is $751.00. The highest price target for IDXX is $830.00, while the lowest price target for IDXX is $640.00. The average price target represents a forecasted upside of 37.97% from the current price of $544.32.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for IDXX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IDXX Analyst Ratings Over Time

Type	Current Forecast 7/26/25 to 7/26/26	1 Month Ago 6/26/25 to 6/26/26	3 Months Ago 4/27/25 to 4/27/26	1 Year Ago 7/26/24 to 7/26/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	5 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$751.00	$751.00	$760.00	$557.88
Forecasted Upside	37.97% Upside	36.17% Upside	32.19% Upside	-1.29% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

IDXX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

IDXX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

IDEXX Laboratories Stock vs. The Competition

Type	IDEXX Laboratories	Medical Companies	Broader Market
Consensus Rating Score	2.60	2.29	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	37.97% Upside	974.40% Upside	14.30% Upside
News Sentiment Rating	Positive News See Recent IDXX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/14/2026	Weiss Ratings 5 of 5 stars		Downgrade	Hold (C+) ➝ Hold (C)
4/28/2026	UBS Group 4 of 5 stars	Andrea Alfonso Not Rated	Lower Target	Neutral	$730.00 ➝ $640.00	+12.36%
4/15/2026	Citigroup 4 of 5 stars	Daniel Grosslight 1 of 5 stars	Initiated Coverage	Buy ➝ Neutral	$650.00	+11.29%
3/31/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$775.00 ➝ $675.00	+21.61%
2/9/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Westenberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$775.00 ➝ $750.00	+16.35%
2/5/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$850.00 ➝ $800.00	+24.43%
2/3/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$830.00 ➝ $800.00	+25.08%
11/4/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$765.00 ➝ $805.00	+11.60%
11/4/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Devas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$830.00	+14.81%
11/4/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Schott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$675.00 ➝ $775.00	+8.13%
This tiny piece of glass could be bigger than GPUs (Ad) A tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it essential for AI to scale, while Sequoia Capital labels it a holy grail. Stocks tied to this technology have already surged 133 percent, 217 percent, and 320 percent in recent months, according to Brownstone Research analyst Jason Bodner, who identified Nvidia at 4.50. Click now to discover Bodner's top AI stock pick before others catch on
11/3/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Clark Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$785.00	+8.58%
2/4/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ryskin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$475.00 ➝ $535.00	+14.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:00 PM ET.

Should I Buy IDEXX Laboratories Stock? IDXX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 20, 2026. Please send any questions or comments about these IDEXX Laboratories pros and cons to contact@marketbeat.com.

IDEXX Laboratories
Bull Case

Here are some ways that investors could benefit from investing in IDEXX Laboratories, Inc.:

The company reported strong earnings per share (EPS) of $3.47 for the latest quarter, exceeding expectations, which indicates robust financial performance and potential for continued growth.
IDEXX Laboratories, Inc. has a high net margin of approximately 24.63%, suggesting efficient management and profitability, which can be attractive to investors looking for financially sound companies.
The current stock price is around $720, reflecting a solid market position and investor confidence in the company's future prospects.
Revenue growth of about 14.3% compared to the same quarter last year demonstrates the company's ability to expand its market share and increase sales, which is a positive indicator for future performance.
Analysts have a consensus rating of "Moderate Buy" with a target price of approximately $751, suggesting that there is potential for price appreciation in the stock.

IDEXX Laboratories
Bear Case

Investors should be bearish about investing in IDEXX Laboratories, Inc. for these reasons:

Recent price target reductions by analysts, such as UBS Group lowering their target from $730 to $640, may indicate concerns about the stock's short-term performance.
Despite strong earnings, the stock has faced downgrades from some analysts, which could signal a lack of confidence in the company's ability to maintain its growth trajectory.
The competitive landscape in the diagnostic products market is intense, which could pressure IDEXX Laboratories, Inc.'s market share and profitability in the future.
With a high return on equity of 70.87%, while impressive, it may also suggest that the company is operating at a high risk, which could deter more risk-averse investors.
Market volatility and economic uncertainties could impact the company's performance, making it a less attractive option for conservative investors.

IDXX Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for IDEXX Laboratories is $751.00, with a high forecast of $830.00 and a low forecast of $640.00.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IDEXX Laboratories in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" IDXX shares.

According to analysts, IDEXX Laboratories's stock has a predicted upside of 37.97% based on their 12-month stock forecasts.

Over the previous 90 days, IDEXX Laboratories's stock had 2 downgrades and 1 upgrade by analysts.

IDEXX Laboratories has been rated by research analysts at UBS Group, and Weiss Ratings in the past 90 days.

Analysts like IDEXX Laboratories more than other "medical" companies. The consensus rating for IDEXX Laboratories is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how IDXX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With IDEXX Laboratories Recommendations

This page (NASDAQ:IDXX) was last updated on 7/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEXX Laboratories (IDXX) Stock Forecast & Price Target